Rothberg, B. E. G., Moeder, C. B., Kluger, H., Halaban, R., Elder, D. E., Murphy, G. F., . . . Rimm, D. L. (2008). Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.
Chicago-стиль цитированияRothberg, Bonnie E Gould, et al. Nuclear to Non-nuclear Pmel17/gp100 Expression (HMB45 Staining) As a Discriminator between Benign and Malignant Melanocytic Lesions. 2008.
MLA-цитированиеRothberg, Bonnie E Gould, et al. Nuclear to Non-nuclear Pmel17/gp100 Expression (HMB45 Staining) As a Discriminator between Benign and Malignant Melanocytic Lesions. 2008.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.